Sign in

CIK 0002010788 · <br>Emerging growth company

EXOZYMES INC.

Sign in to watch
Ticker
EXOZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
834550057
Phone
(626) - 415 - 1488
Business address
750 ROYAL OAKS DR, MONROVIA, CA, 91016
Former names
Invizyne Technologies Inc
Open-market buys, last 90 days
$6,405
in 1 filing
Open-market sales, last 90 days
$19,427
in 1 filing

Net −$13,021. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-09 Korman Tyler Paz Chief Scientific Officer Sale −750 $10.53 $8K 729,123
2026-04-08 Korman Tyler Paz Chief Scientific Officer Sale −750 $10.04 $8K 729,873
2026-04-01 Perriman Damien Alan Chief Commercial Officer Grant or award +62,759 62,759
2026-04-01 Perriman Damien Alan Chief Commercial Officer Grant or award · Stock Option for Common Stock +146,437 146,437
2026-04-01 Perriman Damien Alan Chief Commercial Officer Grant or award +8,887 $8.44 $75K 0
2026-04-01 Opgenorth Paul Hideo Vice President, Development Grant or award +3,999 $8.44 $34K 645,149
2026-04-01 Nawaz Fouad Vice President- Finance Grant or award +5,999 $8.44 $51K 9,488
2026-04-01 Korman Tyler Paz Chief Scientific Officer Grant or award +5,332 $8.44 $45K 730,623
2025-07-02 Heltzen Michael Chief Executive Officer Purchase +1,040 $10.22 $11K 10,628.8
2025-06-17 Heltzen Michael Chief Executive Officer Grant or award · Stock Options for Common Stock +235,817 235,817
2025-06-16 Korman Tyler Paz Vice President, Research Grant or award +2,990 $12.54 $37K 725,291
2025-06-13 Opgenorth Paul Hideo Vice President, Development Grant or award +2,990 $12.54 $37K 641,150
2025-06-13 Nawaz Fouad Vice President, Finance Grant or award +3,489 $12.54 $44K 3,489
2025-01-17 Heltzen Michael Chief Executive Officer Purchase +1,767 $10.78 $19K 3,872
2025-01-16 Heltzen Michael Chief Executive Officer Purchase +121 $10.72 $1K 2,105
2024-11-15 Heltzen Michael Chief Executive Officer Purchase +1,984 $11.10 $22K 1,984
2024-11-08 Opgenorth Paul Hideo Vice President, Development Conversion +2,344 $6.40 $15K 640,504
2024-11-08 MDB Capital Holdings, LLC 10% owner Conversion +122,657 $6.40 $785K 3,931,133

Page 2 of 2 · 38 trades